Table 1—

Age-adjusted prevalence of individual metabolic abnormalities of the metabolic syndrome among U.S. adults aged ≥20 years: NHANES III (1988–1994) and NHANES 1999–2000

NHANES III (1988–1994)
NHANES 1999–2000
nAbdominal obesityHypertri-glyceridemiaLow HDL cholesterolHigh blood pressure or medication useHigh fasting glucose (≥110 mg/dl) or medication useHigh fasting glucose (≥100 mg/l) or medication usenAbdominal obesityHypertri-glyceridemiaLow HDL cholesterolHigh blood pressure or medication useHigh fasting glucose (≥110 mg/dl) or medication useHigh fasting glucose (≥100 mg/l) or medication use
Total6,43638.3 (1.0)30.2 (1.1)37.9 (1.3)32.2 (0.8)13.6 (0.6)32.4 (1.1)167744.0 (2.0)32.6 (1.5)39.9 (2.0)39.2 (1.4)13.1 (1.0)30.7 (1.3)
Men3,06930.1 (1.6)35.9 (1.9)36.2 (1.7)36.4 (1.4)17.2 (0.9)41.4 (1.5)84136.0 (2.8)35.6 (2.1)36.6 (2.2)40.9 (2.2)16.3 (1.4)37.7 (2.2)
Women3,36745.7 (1.3)24.6 (1.1)39.7 (1.4)27.9 (0.9)10.4 (0.7)24.1 (1.1)83651.9 (2.4)29.9 (2.1)43.4 (2.6)37.3 (1.8)10.3 (1.0)23.8 (1.5)
  • Data are percent (SE).